Effect of pay-for-performance on cervical cancer screening participation in France

Andrae, B., Andersson, T. M.-L., Lambert, P. C., Kemetli, L., Silfverdal, L., Strander, B., et al. (2012). Screening and cervical cancer cure: Population based cohort study. BMJ (Clinical research ed.), 344, e900.

Anttila, A., von Karsa, L., Aasmaa, A., Fender, M., Patnick, J., Rebolj, M., et al. (2009). Cervical cancer screening policies and coverage in Europe. European Journal of Cancer, 45(15), 2649–2658. doi: 10.1016/j.ejca.2009.07.020 .

Arbyn, M., Raifu, A. O., Weiderpass, E., Bray, F., & Anttila, A. (2009). Trends of cervical cancer mortality in the member states of the European Union. European Journal of Cancer (Oxford, England: 1990), 45(15), 2640–2648. doi: 10.1016/j.ejca.2009.07.018 .

Assurance Maladie. (2016). La ROSP, une amélioration continue en faveur de la qualité et de la pertinence des soins, bilan à 4 ans. http://www.ameli.fr/fileadmin/user_upload/documents/DP_Bilan_ROSP_2015-210416.pdf .

Carrieri, V., & Bilger, M. (2013). Preventive care: Underused even when free. Is there something else at work? Applied Economics, 45(2), 239–253.

Commission des Comptes de la Sécurité Sociale. (2013). fiche éclairage ROSP. http://www.securite-sociale.fr/IMG/pdf/fiche_eclairage_objectifs_sante_publique.pdf .

Constantinou, P., Dray-Spira, R., & Menvielle, G. (2016). Cervical and breast cancer screening participation for women with chronic conditions in France: Results from a national health survey. BMC Cancer, 16(1), 255. doi: 10.1186/s12885-016-2295-0 .

Duport, N., Serra, D., Goulard, H., & Bloch, J. (2008). Which factors influence screening practices for female cancer in France? Revue D’épidémiologie Et De Santé Publique, 56(5), 303–313. doi: 10.1016/j.respe.2008.07.086 .

Duport, N., Salines, E., & Grémy, I. (2014). Premiers résultats de l’évaluation du programme expérimental de dépistage organisé du cancer du col de l’utérus, France, 2010–2012. Bull Epidémiol Hebd, 2014(13–14–15), 228–234. my in reference Duport et al. (2014).

Eijkenaar, F. (2013). Key issues in the design of pay for performance programs. The European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care, 14(1), 117–131. doi: 10.1007/s10198-011-0347-6 .

Eijkenaar, F., Emmert, M., Scheppach, M., & Schöffski, O. (2013). Effects of pay for performance in health care: A systematic review of systematic reviews. Health Policy (Amsterdam, Netherlands), 110(2–3), 115–130. doi: 10.1016/j.healthpol.2013.01.008 .

Emmert, M., Eijkenaar, F., Kemter, H., Esslinger, A. S., & Schoffski, O. (2012). Economic evaluation of pay-for-performance in health care: A systematic review. European Journal of Health Economics, 13(6), 755–767. doi: 10.1007/s10198-011-0329-8 .

Franc, C., & Lesur, R. (2004). Systèmes de rémunération des médecins et incitations à la prévention. Revue économique, 55(5), 901–922.

French, B., & Heagerty, P. J. (2008). Analysis of longitudinal data to evaluate a policy change. Statistics in Medicine, 27(24), 5005–5025. doi: 10.1002/sim.3340 .

Habbema, D., de Kok, I. M., & Brown, M. L. (2012). Cervical cancer screening in the United States and the Netherlands: A tale of two countries. The Milbank Quarterly, 90(1), 5–37. doi: 10.1111/j.1468-0009.2011.00652.x .

Hakama, M., Chamberlain, J., Day, N. E., Miller, A. B., & Prorok, P. C. (1985). Evaluation of screening programmes for gynaecological cancer. British Journal of Cancer, 52(4), 669–673.

HAS. (2010). État des lieux et recommandations pour le dépistage du cancer du col de l’utérus en France.

Hennig-Schmidt, H., Selten, R., & Wiesen, D. (2011). How payment systems affect physicians’ provision behaviour-an experimental investigation. Journal of Health Economics, 30(4), 637–646. doi: 10.1016/j.jhealeco.2011.05.001 .

Hickson, G. B., Altemeier, W. A., & Perrin, J. M. (1987). Physician reimbursement by salary or fee-for-service: Effect on physician practice behavior in a randomized prospective study. Pediatrics, 80(3), 344–350.

Hillman, A. L., Ripley, K., Goldfarb, N., Nuamah, I., Weiner, J., & Lusk, E. (1998). Physician financial incentives and feedback: Failure to increase cancer screening in Medicaid managed care. American Journal of Public Health, 88(11), 1699–1701.

Hu, F. B., Goldberg, J., Hedeker, D., Flay, B. R., & Pentz, M. A. (1998). Comparison of population-averaged and subject-specific approaches for analyzing repeated binary outcomes. American Journal of Epidemiology, 147(7), 694–703.

Jepson, R., Clegg, A., Forbes, C., Lewis, R., Sowden, A., & Kleijnen, J. (2000). The determinants of screening uptake and interventions for increasing uptake: A systematic review. Health Technology Assessment (Winchester, England), 4(14), i–vii, 1–133.

Kaczorowski, J., Hearps, S. J. C., Lohfeld, L., Goeree, R., Donald, F., Burgess, K., et al. (2013). Effect of provider and patient reminders, deployment of nurse practitioners, and financial incentives on cervical and breast cancer screening rates. Canadian Family Physician Médecin De Famille Canadien, 59(6), e282–289.

Kenkel, D. S. (1994). The demand for preventive medical care. Applied Economics, 26(4), 313.

Kiran, T., Wilton, A. S., Moineddin, R., Paszat, L., & Glazier, R. H. (2014). Effect of payment incentives on cancer screening in Ontario primary care. Annals of Family Medicine, 12(4), 317–323. doi: 10.1370/afm.1664 .

Krasnik, A., Groenewegen, P. P., Pedersen, P. A., von Scholten, P., Mooney, G., Gottschau, A., et al. (1990). Changing remuneration systems: Effects on activity in general practice. BMJ (Clinical Research Ed.), 300(6741), 1698–1701.

Larsen, L. P., & Olesen, F. (1996). Characteristics of subgroups of attenders and non-attenders in an organised screening programme for cervical cancer. Journal of Medical Screening, 3(3), 133–139.

Levi, F., Lucchini, F., Negri, E., Franceschi, S., & la Vecchia, C. (2000). Cervical cancer mortality in young women in Europe: Patterns and trends. European Journal of Cancer (Oxford, England: 1990), 36(17), 2266–2271.

Leyden, W. A., Manos, M. M., Geiger, A. M., Weinmann, S., Mouchawar, J., Bischoff, K., et al. (2005). Cervical cancer in women with comprehensive health care access: Attributable factors in the screening process. Journal of the National Cancer Institute, 97(9), 675–683. doi: 10.1093/jnci/dji115 .

Li, J., Hurley, J., Decicca, P., & Buckley, G. (2014). Physician response to pay-for-performance: Evidence from a natural experiment. Health Economics, 23(8), 962–978. doi: 10.1002/(ISSN)1099-1050/issues .

Liang, K.-Y., & Zeger, S. L. (1986). Longitudinal data analysis using generalized linear models. Biometrika, 73(1), 13–22. doi: 10.1093/biomet/73.1.13 .

Lim, A. W. W., & Sasieni, P. (2015). Consultation rates in cervical screening non-attenders: opportunities to increase screening uptake in GP primary care. Journal of Medical Screening, 22(2), 93–99. doi: 10.1177/0969141315573345 .

Maxwell, C. J., Bancej, C. M., Snider, J., & Vik, S. A. (2001). Factors important in promoting cervical cancer screening among Canadian women: Findings from the 1996–97 National Population Health Survey (NPHS). Canadian Journal of Public Health, 92(2), 127–133.

Maynard, A. (2012). The powers and pitfalls of payment for performance. Health Economics, 21(1), 3–12. doi: 10.1002/(ISSN)1099-1050/issues .

Meeker, D., Joyce, G. F., Malkin, J., Teutsch, S. M., Haddix, A. C., & Goldman, D. P. (2011). Coverage and preventive screening. Health Services Research, 46(1 Pt 1), 173–184. doi: 10.1111/j.1475-6773.2010.01188.x .

Miller, A. B. (2002). The (in)efficiency of cervical screening in Europe. European Journal of Cancer (Oxford, England: 1990), 38(3), 321–326.

Mullen, K. J., Frank, R. G., & Rosenthal, M. B. (2010). Can you get what you pay for? Pay-for-performance and the quality of healthcare providers. The Rand Journal of Economics, 41(1), 64–91.

O’Connor, M., Murphy, J., Martin, C., O’Leary, J., Sharp, L., & Irish Cervical Screening Consortium (CERVIVA). (2014). Motivators for women to attend cervical screening: The influential role of GPs. Family Practice, 31(4), 475–482. doi: 10.1093/fampra/cmu029 .

Or, Z., Jusot, F., & Yilmaz, E. (2009). Inégalités de recours aux soins en Europe. Revue économique, 60(2), 521–543.

Palència, L., Espelt, A., Rodríguez-Sanz, M., Puigpinós, R., Pons-Vigués, M., Pasarín, M. I., et al. (2010). Socio-economic inequalities in breast and cervical cancer screening practices in Europe: Influence of the type of screening program. International Journal of Epidemiology, 39(3), 757–765. doi: 10.1093/ije/dyq003 .

Peto, J., Gilham, C., Fletcher, O., & Matthews, F. E. (2004). The cervical cancer epidemic that screening has prevented in the UK. The Lancet, 364(9430), 249–256. doi: 10.1016/S0140-6736(04)16674-9 .

Robinson, J. C. (2001). Theory and practice in the design of physician payment incentives. The Milbank Quarterly, 79(2), 149–177, III.

Rosenthal, M. B., Frank, R. G., Li, Z., & Epstein, A. M. (2005). Early experience with pay-for-performance: From concept to practice. JAMA, 294(14), 1788–1793. doi: 10.1001/jama.294.14.1788 .

Rousseau, A., Bohet, P., Merlière, J., Treppoz, H., Heules-Bernin, B., & Ancelle-Park, R. Evaluation du dépistage organisé et du dépistage individuel du cancer du col de l’utérus?: utilité des données de l’Assurance maladie. BEH.

Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007). Human papillomavirus and cervical cancer. Lancet (London, England), 370(9590), 890–907. doi: 10.1016/S0140-6736(07)61416-0 .

Scott, A. (2000). Chapter 22 economics of general practice. In B.-H. of H. Economics (Ed.), (Vol. 1, Part B, pp. 1175–1200). Elsevier. http://www.sciencedirect.com/science/article/pii/S1574006400800359 . Accessed 16 Sept 2015.

Sicsic, J., & Franc, C. (2014). Obstacles to the uptake of breast, cervical, and colorectal cancer screenings: What remains to be achieved by French national programmes? BMC Health Services Research, 14, 465. doi: 10.1186/1472-6963-14-465 .

Sicsic, J., & Franc, C. (2016). Impact assessment of a pay-for-performance program on breast cancer screening in France using micro data. The European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care,. doi: 10.1007/s10198-016-0813-2 .

Stone, E. G., Morton, S. C., Hulscher, M. E., Maglione, M. A., Roth, E. A., Grimshaw, J. M., et al. (2002). Interventions that increase use of adult immunization and cancer screening services: A meta-analysis. Annals of Internal Medicine, 136(9), 641–651.

Town, R., Kane, R., Johnson, P., & Butler, M. (2005). Economic incentives and physicians’ delivery of preventive care: A systematic review. American Journal of Preventive Medicine, 28(2), 234–240. doi: 10.1016/j.amepre.2004.10.013 .

Tuppin, P., de Roquefeuil, L., Weill, A., Ricordeau, P., & Merlière, Y. (2010). French national health insurance information system and the permanent beneficiaries sample. Revue D’épidémiologie Et De Santé Publique, 58(4), 286–290. doi: 10.1016/j.respe.2010.04.005 .

Van Herck, P., De Smedt, D., Annemans, L., Remmen, R., Rosenthal, M. B., & Sermeus, W. (2010). Systematic review: Effects, design choices, and context of pay-for-performance in health care. BMC Health Services Research, 10, 247. doi: 10.1186/1472-6963-10-247 .